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1. Abstract 
Objective: There is inconsistency and controversy in quantifying how much reduction in 
pain is clinically meaningful for low back pain patients undergoing various treatments. In 
the present study we analyzed the association between pain reduction on the 'Numeric 
Rating Scale' for pain (NRS) and a clinically significant improvement at various treat-
ment outcome time points in low back pain patients who have undergone chiropractic 
treatment. The purposes were to determine absolute and percentage pain reduction va-
lues that are associated with clinically relevant improvement in these patients and to 
compare the results of acute and chronic patients. 
Methods: Data from 895 patients with low back pain were collected. Forty-four Doctors 
of Chiropractic practicing in different parts of Switzerland contributed to the data gathe-
ring between May 2010 and May 2014. Before treatment, patients filled out forms inclu-
ding the NRS, the Oswestry disability index questionnaire (ODI) and the 'Patients Glo-
bal Impression of Change' scale (PGIC). Follow-up data collection was completed 1 
Week, 1 month and 3 months after the first treatment by using short telephone inter-
views executed by trained research assistants. The changes of the NRS scores from 
baseline were calculated using the Wilcoxon test for matched pairs. To compare absolu-
te and percentage NRS score changes between 'improved' and 'not improved' patients, 
the unpaired Student's t-test was used. A one-way ANOVA was done to compare the 
scores between acute and chronic patients and the χ2 test was used to calculate the 
proportions of acute and chronic patients regarding 'improvement'. 
Results: Absolute and percentage pain reduction values on the NRS associated with 
'improvement' on the PGIC scale differed significantly between acute and chronic pati-
ents and changed significantly depending on the assessment time point. Acute patients 
always showed significantly higher reduction values associated with 'improvement' in 
comparison to chronic patients. In acute patients, mean values of pain reduction asso-
ciated with improvement ranged from 3.63 - 5.00 points (absolute), corresponding to a 
56.8% - 78.19% decrease, depending on the assessment time point. In chronic pati-
ents, mean values of pain reduction associated with improvement ranged from 1.97 - 
3.23 points (absolute), corresponding to a 33.92% - 51.42% decrease, depending on 
the assessment time point. 
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Conclusions: The results of the present study provide evidence that pain reduction va-
lues associated with significant improvement in low back pain patients are significantly 
dependent on the patients chronicity as well as on the data assessment time point. The-
refore, the concept of a single value for 'minimal clinically important difference' (MCID) 
should be questioned. 
"5
2. List of abbreviations  
DC    Doctor of Chiropractic 
LBP    Low Back Pain 
MCID    Minimum/Minimal Clinically Important Difference 
NRS    Numeric Rating Scale for pain 
ODI    Oswestry Disability Index 
PGIC    Patients Global Impression of Change 
SD    Standard Deviation 
VAS    Visual Analog Scale for pain 
ΔNRS abs.    Absolute NRS change 
ΔNRS %   Percentage change of the NRS 
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3. Introduction  
In 1989, Jaeschke et al. [1] defined the minimal clinically important difference (MCID) as 
“the smallest difference in a score of a domain of interest that patients perceive to be 
beneficial”. Since then, MCIDs have been investigated and calculated for different out-
come measures, but so far there is no gold standard in the method of how to determine 
or calculate the MCID [2]. There is inconsistency and controversy in quantifying how 
much reduction in pain on the widely used and validated [3 - 6] numeric rating scale 
(NRS) is clinically meaningful for low back pain patients undergoing various treatments 
[2]. It has therefore been suggested that the required quantity of change depends on 
multiple factors such as the underlying condition, the type of treatment, the characteris-
tics of the patients as well as the type of outcome measures or the administered proce-
dures used to assess the improvement [2, 7]. As expected, the MCIDs found in current 
back pain studies vary significantly [2]. Some studies state that a 2 point reduction on 
the numeric rating scale is meaningful to the patient [6, 8 - 11]. Other studies have found 
percentage changes, mostly with values of approximately 30% reduction of the baseline 
pain score, to be more accurate in order to describe a minimal clinically meaningful 
change [4, 6, 9 - 11]. Intuitively, a percentage change in pain seems more reasonable as a 
2 point pain reduction could range from only 20% to 100% pain reduction depending 
upon the baseline pain score. 
In the present study we analyzed the association between pain reduction on the nume-
ric rating scale and a clinically significant improvement at various treatment outcome 
time points in low back pain patients who have undergone chiropractic treatment. To de-
termine whether the patients improved, the patients global impression of change (PGIC) 
scale was used, which has been stated to provide the single best measure of the signi-
ficance of an improvement from the patients’ perspective [12]. The PGIC has been used 
in other comparable outcome measure studies [11, 13]. Reference values for clinically 
relevant pain reduction after predefined treatment periods could enable practitioners to 
identify non-responders earlier and by changing or modifying the applied treatment, bet-
ter outcomes might be achieved. Also the data will contribute to the ongoing discussion 
about pain MCIDs in different patient populations. 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Therefore, the purposes of this study were to determine: 
A) What percentage of pain reduction is associated with clinically relevant improvement 
in acute and chronic low back pain patients at various treatment outcome time points? 
B) How many points reduction on the numeric rating scale is associated with a clinically 
relevant improvement in acute and chronic low back pain patients? 
C) Do acute and chronic patients need the same amount of pain reduction to significant-
ly 'improve'? 
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4. Methods  
This is a secondary analysis from a prospective cohort outcomes study [14] on low back 
pain patients undergoing chiropractic treatment. 
4.1 Setting   
Data were collected between May 2010 and May 2014. All of the 260 active members of 
the Swiss Chiropractic Association were asked to participate in collecting the data for 
the study. Forty-four Doctors of Chiropractic (DC) practicing in different parts of Switzer-
land contributed patients to the study. Data on between 5 to 85 patients were collected 
per participating DC. Thirteen of the DCs contributed 20 or more patients to the study. 
The chiropractors received written instructions and the study protocol per e-mail. Fur-
thermore, immediately prior to the start of the study, verbal instructions were given to 
them at the annual postgraduate convention, which is an event with mandatory atten-
dance for Swiss Chiropractic Association members. Workshops about the use of out-
come measures in practice were given by one of the authors (B.K.H.). DCs who were 
interested in participating in the study had to attend these workshops. 
4.2 Patients  
The recruitment of the patients was done by the participating DCs who were asked to 
inform all patients meeting the inclusion and exclusion criteria about the study and en-
courage them to participate. This process was not monitored by the study‘s committee 
but periodic e-mail reminders were sent to the DCs. 
Inclusion criteria 
- New LBP patients 
- At least 18 years old 
- No chiropractic or other manual therapy received within the past 3 months 
Exclusion criteria 
- Relative or absolute contraindications to chiropractic manipulative treatment including: 
- Tumors, inflammatory spondyloarthropathies, infections, severe osteoporosis, acute 
fractures or Paget‘s disease 
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4.3 Treatment 
As the aim of the study was to investigate the outcomes of routine chiropractic practice, 
participating DCs were instructed to treat patients just as usual. There was no prede-
termined treatment number or treatment method and no specific treatment methods 
were excluded. However, it is known from a ‚Job Analysis Survey‘ in 2009 that Swiss 
Chiropractors use the "diversified" technique on between 76 and 100% of their patients. 
Other commonly used techniques and treatment options include mobilization techni-
ques, trigger-point therapy, therapeutic exercises and advice on the activities of daily 
living [15]. 
4.4 Outcome Measures 
The following outcome measures were used: 
The ‚Numeric Rating Scale‘ for pain (NRS): The NRS is an 11-point rating scale ranging 
from 0 to 10, 0 meaning 'no pain' and 10 meaning 'the worst pain imaginable'. The NRS 
and the widely used ‚Visual Analog Scale‘ for pain (VAS) have been shown to give al-
most identical values in the same patients, but the NRS is better suited for telephone 
follow-up data collection as done in this study [16 - 19]. 
‚Patients Global Impression of Change‘ questionnaire (PGIC): The PGIC consists of a 7-
point verbal scale including responses of much worse (score of 7), worse, slightly 
worse, no change, slightly better, better, and much better (score of 1) [13]. To determine 
whether patients improved, the answers were dichotomized into 2 groups. Patients fee-
ling better or much better (scores of 1 or 2) were categorized as 'improved', all other pa-
tients were categorized as 'not improved'. Using the dichotomization of the PGIC to de-
termine significant improvement has been found valid, reliable and it has been used ex-
actly the same way in other studies [13, 14, 20 - 22]. The dichotomized PGIC is the prima-
ry outcome measure in the study. 
Immediately before their first treatment, enrolled patients were given 2 different forms 
for completion. One of these was the NRS and the other one the Oswestry Disability 
Index (ODI). The forms were available in German and French as they are the most fre-
quently used languages in Switzerland. Further information was gathered by the DCs 
including patient sex, age, whether or not the onset of pain was caused by trauma, du-
ration of current complaint, number of previous episodes, presence or absence of radi-
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culopathy, presence or absence of referred leg pain, current use of pain medication, 
work status, marital status, whether the patient smokes, patient's general health status 
and the working diagnosis. To make sure that all of the DCs used the terms "radiculopa-
thy" and "referred leg pain" the same, it was emphasized that radiculopathy meant the 
specific signs and symptoms of nerve root compression being different from "referred 
leg pain" which has no radicular pattern. One week after the first consultation, patients 
received a short telephone call conducted by trained research assistants unknown to 
the patient or the referring DCs. In these short interviews, data from the PGIC, NRS and 
ODI were collected. The same procedure was repeated 1 month and 3 months after the 
first treatment, irrespective of whether or not the patient still was in chiropractic care. 
4.5 Statistics  
The Wilcoxon test for matched pairs was used to calculate the changes of the NRS 
scores from baseline to the various time frames during and after treatment. 
The unpaired Student's t-test was used to compare the NRS actual change scores 
(normally distributed data) and the NRS percentage change scores between 'improved' 
and 'not improved' patients for each outcome time point. This was done with the whole 
cohort data as well as with the data of the acute and the chronic patients separately. To 
compare the scores between acute patients (symptoms < 4 weeks in duration) and 
chronic patients (symptoms > 3 months in duration), a one-way ANOVA was done. The 
proportions of 'acute' and 'chronic' patients regarding 'improvement' were calculated and 
compared for significant differences in proportions using the χ2 test with two-tailed P va-
lues. 
Due to the narrow time slots in which the follow-up data was allowed to be gathered, 
some follow-up data are missing. These patients were nonetheless included in the sta-
tistics if data from other outcome time points was available. Patients with pre-treatment 
NRS < 1 or missing pre-treatment NRS data were excluded in the final statistics. 
4.6 Ethics   
Ethics approval was obtained from the Orthopaedic University Hospital of Balgrist ethics 
committee and Canton of Zürich ethics review board (ethics approval number: EK 
16/2009). A written informed consent was obtained from all patients. 
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5. Results 
5.1 Patients characteristics  
The data of 895 patients matched with the inclusion and exclusion criteria and were the-
refore included in the final statistics. Of these, 505 (56.4%) were rated as 'acute' (< 4 
weeks of symptoms), 274 (30.6%) were rated as 'chronic' (> 12 weeks of symptoms), 
103 (11.5%) had symptoms between 4 and 12 weeks and were rated as 'subacute', 13 
(1.5%) patients had missing data of the chronicity. 
The age ranged from 18 to 85 years with an overall mean of 43.64 ('acute' mean = 
42.62; 'chronic' mean = 44.78) and a SD of 14.41 ('acute' SD = 14.19; 'chronic' SD = 
14.45). 
Pre-Treatment NRS scores included in the final statistics ranged between 1 and 10, with 
an overall mean of 5.87 ('acute' mean = 6.20; 'chronic' mean = 5.41) and a SD of 2.13 
('acute' SD = 2.08; 'chronic' SD = 2.06). The most frequently reported pre-treatment 
NRS scores were 7 (16.4%), 5 (13.2%) and 8 (11.8%). 
5.2 Overall improvement measured by the PGIC 
As acute and chronic patients had different outcomes, the presented data are divided 
into 'All LBP Patients', 'Acute LBP Patients' and 'Chronic LBP Patients'. The overall out-
comes between acute and chronic LBP patients differ notably with a significantly higher 
percentage of 'acute' patients having improved compared to the 'chronic' patients at all 
given assessment time points (p<0.005; see also chapter 5.6). These percentage va-
lues can be seen in Table 1, showing the overall improvement in all the patients as well 
as in acute and chronic patients separately, measured by the PGIC. 
In the 'All LBP Patients' group, at 1 week, 385 patients have improved, 354 have not. At 
1 month, 499 have improved versus 198 who have not improved. At 3 months, 438 
have improved versus 111 who have not improved. 
In the 'Acute LBP Patients' group, at 1 week, 274 of the patients have improved, 140 
have not improved. At 1 month, 323 patients have improved and 72 have not improved. 
At 3 months, 265 have improved versus 35 who have not improved. 
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In the 'Chronic LBP Patients' group, at 1 week, 73 of the patients have improved, 160 
have not improved. At 1 month, 124 have improved, 90 have not improved. At 3 months 
125 of the patients have improved and 56 have not improved. 
As some follow-up data are missing, the number of patients is inconsistent over time. 
Table 1: Overall improvement (PGIC) of all patients, acute & chronic patients 
5.3 Mean Pain improvement over time  
Table 2 shows the mean NRS changes and standard deviations over time in all measu-
red LBP patients, as well as in acute and chronic LBP patients separately. 
Table 2: Mean NRS changes after 1 week, 1 month and 3 months 
ΔNRS abs. = absolute NRS change. ΔNRS % = percentage change of the NRS. SD = standard deviation. 
1 Week 1 Month 3 Months
All LBP  
Patients
improved 52.2% 71.5% 79.7%
not improved 47.8% 28.5% 20.3%
Acute LBP 
Patients
improved 66.2% 81.8% 88.3%
not improved 33.8% 18.2% 11.7%
Chronic LBP 
Patients
improved 31.3% 57.9% 69%
not improved 68.7% 42.1% 31%
1 Week 
Mean (SD)
1 Month 
Mean (SD)
3 Months  
Mean (SD)
All
ΔNRS abs. 2.09 (2.48) 3.24 (2.74) 3.71 (2.88)
ΔNRS % -30.01 (45.46) -50.04 (45.01) -55.98 (53.82)
Acute
ΔNRS abs. 2.84 (2.47) 4.09 (2.74) 4.61 (2.63)
ΔNRS % -42.99 (37.9) -62.37 (41.32) -71.29 (34.28)
Chronic
ΔNRS abs. 1.08 (2.06) 2.07 (2.20) 2.45 (2.76)
ΔNRS % -14.08 (44.48) -34.58 (38.45) -34.7 (65.94)
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5.4 Mean NRS changes in all 'improved' and in all 'not improved' patients  
Table 3 shows the mean NRS changes and the standard deviations of all LBP patients, 
depending on the PGIC category ('improved' or 'not improved'). 
The t-tests showed significantly (p<0.005) different NRS changes over time (absolute 
and percentage) between the 'improved' group and the 'not improved' group at all given 
assessment time points (1 week, 1 month, 3 months). 
Table 3: Mean NRS changes over time in all 'improved' and in all 'not improved' patients 
ΔNRS abs. = absolute NRS change. ΔNRS % = percentage change of the NRS. SD = standard deviation. 
5.5 Comparison of acute with chronic patients for the mean NRS changes over 
time in 'improved' and in 'not improved' patients 
 
Tables 4, 5 and 6 show the mean NRS changes and the standard deviations depending 
Mean (SD)
P-Value (ΔNRS in 'impro-
ved' vs. ΔNRS in 'not im-
proved' patients)
ΔNRS abs. 
1 Week
improved 3.21 (2.42)
p<0.005
not improved 0.84 (1.86)
ΔNRS %  
1 Week
improved -50.47 (36.83)
p<0.005
not improved -7.44 (43.25)
ΔNRS abs. 
1 Month
improved 4.12 (2.50)
p<0.005
not improved 1.02 (1.95)
ΔNRS %  
1 Month
improved -65.62 (34.43)
p<0.005
not improved -10.72 (44.91)
ΔNRS abs. 
3 Months
improved 4.38 (2.56)
p<0.005
not improved 1.12 (2.53)
ΔNRS %  
3 Months
improved -69.23 (34.70)
p<0.005
not improved -4.13 (78.91)
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on the PGIC category ('improved' or 'not improved') and the chronicity category ('acute' 
or 'chronic'). 
The t-tests showed significantly (p<0.005) different NRS changes over time (absolute 
and percentage) between the 'improved' group and the 'not improved' group at all given 
assessment time points (1 week, 1 month, 3 months) in acute patients as well as in 
chronic patients. 
 
Table 4: Comparison of acute with chronic patients for the mean NRS changes in 'im-
proved' and in 'not improved' patients at 1 week: 
ΔNRS abs. = absolute NRS change. ΔNRS % = percentage change of the NRS. SD = standard deviation. 
 
Table 5: Comparison of acute with chronic patients for the mean NRS changes in 'im-
proved' and in 'not improved' patients at 1 month: 
ΔNRS abs. = absolute NRS change. ΔNRS % = percentage change of the NRS. SD = standard deviation. 
Acute Chronic
ΔNRS abs. 
1 Week
ΔNRS %  
1 Week
ΔNRS abs. 
1 Week
ΔNRS %  
1 Week
Mean 
(SD)
improved
3.63 
(2.32)
-56.80 
(30.68)
1.97 
(2.26)
-33.92 
(42.93)
not improved
1.21 
(1.89)
-15.32 
(35.52)
0.67 
(1.83)
-5.04 
(42.30)
P-Value (ΔNRS in 'improved' 
vs. ΔNRS in 'not improved')
p<0.005 p<0.005 p<0.005 p<0.005
Acute Chronic
ΔNRS abs. 
1 Month
ΔNRS %  
1 Month
ΔNRS abs. 
1 Month
ΔNRS %  
1 Month
Mean 
(SD)
improved
4.74 
(2.41)
-72.96 
(31.34)
2.77 
(2.23)
-49.09 
(35.32)
not improved
1.17 
(2.22)
-14.69 
(47.18)
1.08 
(1.74)
-14.34 
(33.43)
P-Value (ΔNRS in 'improved' 
vs. ΔNRS in 'not improved')
p<0.005 p<0.005 p<0.005 p<0.005
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Table 6: Comparison of acute with chronic patients for the mean NRS changes in 'im-
proved' and in 'not improved' patients at 3 months: 
ΔNRS abs. = absolute NRS change. ΔNRS % = percentage change of the NRS. SD = standard deviation. 
5.6 Comparison of the 'acute' group and the 'chronic' group (one-way ANOVA and 
χ2 test) 
The ANOVA showed significant (p<0.005) differences between the 'acute' group and the 
'chronic' group at all assessment time points (1 week, 1 month, 3 months) in terms of 
the clinically relevant absolute and percentage NRS changes. 
The association between the chronicity ('acute' or 'chronic') and the improvement cate-
gory ('improved' or 'not improved'), measured by the χ2 test with two-tailed P values, 
has been shown to be highly significant (p<0.0001) at all given assessment time points 
(1 week, 1 month and 3 months). 
Acute Chronic
ΔNRS abs. 
3 Months
ΔNRS %  
3 Months
ΔNRS abs. 
3 Months
ΔNRS %  
3 Months
Mean 
(SD)
improved
5.00 
(2.39)
-78.19 
(27.55)
3.23 
(2.48)
-51.42 
(40.65)
not improved
1.89 
(2.56)
-22.19 
(35.87)
0.67 
(2.56)
2.60 
(91.95)
P-Value (ΔNRS in 'improved' 
vs. ΔNRS in 'not improved')
p<0.005 p<0.005 p<0.005 p<0.005
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6. Discussion 
6.1 Key Findings 
One of the main key findings of the study was that not only do the outcomes of acute 
and chronic patients significantly differ, but also their mean absolute and percentage 
NRS changes that are associated with a clinically relevant improvement on the PGIC 
scale, at all of the assessment time points are different. This strongly suggests that a 
single NRS value in terms of points or percentage of the NRS reduction equating to cli-
nically relevant 'improvement' is not applicable to all patients undergoing chiropractic 
treatment for low back pain. What patients consider to be clinically relevant pain reduc-
tion differs between acute and chronic patients. This is important for research studies 
evaluating clinically relevant pain reduction after various treatments. After 1 week for 
example, the mean NRS change in 'acute' patients that was associated with 'improve-
ment' on the PGIC scale was 3.63 (absolute) which equates to a 56.8% decrease in re-
lation to the pre-NRS score, whereas chronic patients who reported clinically relevant 
improvement had a mean NRS reduction of 1.97 NRS points (absolute) corresponding 
to a 33.92% reduction. The clinically relevant values obtained after 1 month and 3 
months also differed significantly between the acute and chronic patients, with acute pa-
tients always having higher absolute and percentage change values that they deemed 
clinically relevant compared to the chronic patients. 
The mean values obtained of absolute and percentage NRS change in 'improved' pati-
ents were always higher than the proposed 2 point reduction on the NRS scale [6, 8 - 11] 
and the 30% or 33% decrease reported in the literature [4, 6, 9 - 11] as a MCID, with the 
exception of the absolute NRS change value in the 'chronic' group at 1 week (1.97) 
which was almost 2 points with a corresponding percentage change of just under 34%. 
Consistent with previously reported studies was that the obtained mean values in 'not 
improved' patients were always lower than the proposed MCID values. 
6.2 Comparison of results with results of other studies  
The mean NRS change values for 'chronic' patients at 1 week (1.97 points absolute, 
-33.92%) are consistent with the often suggested values of 2 points pain reduction [6, 8 - 
11], or 30% to 33% pain reduction [4, 6, 9 - 11]. 
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The values representing clinically relevant 'improvement' found in the 'acute' group were 
much higher than the proposed MCID values found in the previously mentioned studies 
that were realized with chronic LBP patients.  
However, higher MCID values for acute LBP patients in comparison to chronic LBP pa-
tients have been proposed before with absolute NRS change values of 3.5 - 4.7 points 
in acute patients compared to 2.5 - 4.5 points in chronic patients [23, 24], depending on 
the methods that have been used to determine the MCID. Our results demonstrated 
that the MCIDs of acute and chronic patients differ significantly. Therefore, the MCID 
should not be seen as a fixed value, as it strongly depends on the patient population 
(more chronic patients will lead to lower MCIDs, more acute patients will lead to higher 
MCID estimations) and the methods used to determine the MCID [23 - 25]. However, the-
re is little literature found regarding MCIDs in acute LBP patients. 
6.3 Strengths and limitations of the study  
Strengths: 
One of the strengths of the present study is the large number of patients in both the 
acute and chronic categories providing strong power for the results. An important 
strength of this study is that the validated Patient’s Global Impression of Change (PGIC) 
scale to determine clinically relevant ‘improvement’ was used as the primary outcome 
measure and thus the NRS pain change scores could be compared to this outcome 
measure [4, 6, 11, 13, 14, 20 - 22]. This gives confidence that the NRS values obtained 
when determining clinically relevant improvement in the acute and chronic patients are 
valid and reliable. 
Given the fact that 44 doctors of chiropractic in different parts of Switzerland have cont-
ributed to the data acquisition, this study provides results derived from the outcomes of 
typical chiropractic practice in Switzerland. As different therapeutic methods have been 
used by the participating chiropractic doctors, the study cannot make any conclusions 
regarding the efficacy of different methods being used to treat low back pain and there-
fore the results could have turned out differently if the data would have been collected in 
another country with other therapeutic methods that are commonly used. However, this 
was not the aim of the study. 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Limitations:  
In the present study, patients were categorized only into 2 groups: 'acute' and 'chronic'. 
As there was such a significant difference between these groups, the question is if the 
patients should have been divided into more chronicity groups, and in general, if diffe-
rent MCIDs should be determined for patients with different chronicities such as acute, 
subacute, chronic or even for further subcategories. It is possible that depending on the 
chronicity, patients rate their pain differently. Whereas in acute patients pain could be 
the most disturbing part of their consulting issue, chronic patients who are used to ha-
ving pain could suffer more from disabilities or movement restrictions rather than pain or 
they appreciate smaller changes of their pain levels more than acute patients who ex-
pect being pain free after a treatment. The MCID could also depend on how long it ta-
kes after the start of treatment until the pain declines. 'Acute' patients with no improve-
ment after 3 months had a mean absolute NRS-change of 1.89 points (respectively 
-22.19%). Considering the standard deviation (2.56 points, 35.87%), there were patients 
with more than 2 points or 30% of NRS decrease that still felt 'not improved' while 
others already reported improvement at lower NRS-change levels. One possible expla-
nation is that the MCID rises simultaneously with the amount of elapsed time since the 
beginning of the treatment because the change is slower and therefore less noticeable. 
Another plausible explanation of these values is that the patients feel 'not improved' de-
spite having less pain. This could be due to unfavorable psychological or social situati-
ons/conditions, movement restrictions or disabilities. In such cases the biopsychosocial 
model [26] should be used for a prognosis concerning 'improvement' rather than looking 
at pain as a single contributing factor for the well-being of a patient. 
In this study the association between a decrease on the NRS and an improvement on 
the PGIC scale was studied. Mean values were analyzed at different assessment time 
points. These mean values do not necessarily represent the same as a MCID. After 1 
month and 3 months the mean absolute and percentage values associated with an im-
provement on the PGIC scale increased over time. The most likely explanation for this 
is that patients having already improved were still continuing to improve after the first 
week, which had an influence on the subsequently measured mean values. Therefore, 
to determine the MCID by using the NRS compared to the PGIC, early reports of impro-
vement should be used. The NRS change should be measured as soon as possible af-
ter the individual change from 'not improved' to 'improved', so further improvement 
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would not have an effect on the reported NRS change leading to an 'improved' on the 
PGIC scale and therefore would not have an effect on the estimated MCID value. 
6.4 Conclusion 
The results of this study indicate that the MCID depends strongly on the chronicity of 
the patients as well as on the data assessment time points, and therefore single values 
as minimally clinically important pain reductions are not appropriate for all patients. 
To obtain NRS change values most close to the MCID, patients should be surveyed as 
soon as possible after treatment. 
As the PGIC provides an outcome measure for the overall improvement of a patient, 
regardless of the cause leading to the improvement, there are many factors that can 
contribute to a change from 'not improved' to 'improved' and the pain measured by the 
NRS should not be isolated and considered to play the decisive role leading to the 
change. A change on the PGIC scale can be seen as the result of an overall-improve-
ment of the patients biopsychosocial condition. 
6.5 Remaining uncertainties  
As the results of NRS changes associated with an improvement on the PGIC scale vary 
significantly depending on the chronicity and the elapsed time between treatment start 
and the data gathering, the question arises whether or not different MCIDs should be 
applied in different patient subgroups. 
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